Synlogic SYBX
Synlogic Q2 FY24: revenue $0; diluted EPS $0.16
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000950170-24-093282
Key figures from this report
These are the numbers Synlogic reported for Q2 FY24, the quarter ended Jun 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$0No year-earlier figure tagged10-Q income statement, on EDGAR
- Net income$2.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS$0.16No year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$20.0MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
- Cash from operations−$15.0MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Matinas BioPharma Holdings MTNB public float $5M, Jun 30, 2025
- China Pharma Holdings CPHI public float $4M, Jun 30, 2025
- Soligenix SNGX public float $5M, Jun 30, 2025
- Target Group CBDY public float $5M, Jun 30, 2025
- Creative Medical Technology Holdings CELZ public float $5M, Jun 30, 2025
